Cardiovascular Activity Alteration [PE]
Cardiovascular Activity Alteration
N0000008331
http://purl.bioontology.org/ontology/NDFRT/N0000008331
Organ System Specific Effects [PE]
PHYSIOLOGIC_EFFECT_KIND
CITRATED CAFFEINE
HYOSCYAMINE SO4 0.125MG TAB,ORAL DISINTEGRATING [VA Product]
CAFFEINE 200MG TAB [VA Product]
CAFFEINE 100MG TAB [VA Product]
CAFFEINE,CITRATED 65MG TAB [VA Product]
HYOSCYAMINE SO4 0.375MG TAB,SA [VA Product]
HYOSCYAMINE SO4 0.125MG TAB,SUBLINGUAL [VA Product]
HYOSCYAMINE SO4 0.15MG TAB [VA Product]
HYOSCYAMINE SO4 0.13MG TAB [VA Product]
HYOSCYAMINE SO4 0.125MG/ML DROPS,ORAL [VA Product]
HYOSCYAMINE SO4 0.125MG/5ML ELIXIR [VA Product]
HYOSCYAMINE SO4 0.375MG CAP,SA [VA Product]
HYOSCYAMINE SO4 0.125MG TAB [VA Product]
CAFFEINE
CAFFEINE CITRATE 20MG/ML INJ [VA Product]
HYOSCYAMINE SO4 0.5MG/ML INJ [VA Product]
HYOSCYAMINE HYDROBROMIDE
HYOSCYAMINE
HYOSCYAMINE SULFATE
Organ or Tissue Function
T042
C1371291